Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
49.30
-1.70 (-3.33%)
At close: Dec 4, 2025
-7.85% (1Y)
| Market Cap | 5.30B |
| Revenue (ttm) | 9.52B |
| Net Income (ttm) | 537.75M |
| Shares Out | 107.42M |
| EPS (ttm) | 4.99 |
| PE Ratio | 9.89 |
| Forward PE | n/a |
| Dividend | 1.40 (2.84%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 279,736 |
| Average Volume | 331,215 |
| Open | 51.00 |
| Previous Close | 51.00 |
| Day's Range | 48.90 - 51.50 |
| 52-Week Range | 42.00 - 65.80 |
| Beta | -0.20 |
| RSI | 41.97 |
| Earnings Date | Jan 22, 2026 |